Alliances
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
PNI will handle development of the vaccine and CanSinoBIO will take care of preclinical testing, human clinical trials, regulatory submissions and commercialization.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
Weeks after Mammoth Biosciences announced its CRISPR-based diagnostics test for COVID-19 had a high degree of specificity even for asymptomatic patients, the company has struck a deal with GSK to accelerate development of the test in hopes of getting them in consumer hands as soon as possible.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.
As part of the agreement, Phlow will help build the United States’ first Strategic Active Pharmaceutical Ingredients Reserve, a long-term, national stockpile to secure key ingredients used to manufacture the most essential medicines in the United States.
Research conducted under the collaboration will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns through the use of relevant and new data sources.
The companies will leverage Vividion’s proteomics screening platform and small molecule library to target novel E3 ligases in addition to a variety of oncology and immunology therapy targets.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 19, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 18, 2020.
PRESS RELEASES